Healthpeak Properties has delivered a strong 33.7% year to date return, yet its valuation signals are pulling in different directions, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while market based multiples suggest the stock screens as expensive. That split, along with a low overall value score, puts the recent share price performance under closer scrutiny for investors trying to judge whether the current level offers enough compensation for the risks.

• Healthpeak Properties is up 33.7% year to date, which puts more weight on whether today’s price is supported by the company’s long term cash flow potential.
• The intrinsic value estimate using a Discounted Cash Flow (DCF) approach indicates the stock may be undervalued by about 43.1%, but the key risk is that future cash flows could come in lower or later than currently implied.
• On broader checks Healthpeak Properties only scores 2 out of 6 on valuation, which leans more toward the stock not being a clear bargain when viewed across several methods.

The issue now is whether Healthpeak Properties’ recent gains already reflect its cash flow potential, or if the Discounted Cash Flow (DCF) upside still leaves a reasonable margin of safety in the current share price.

Is Healthpeak Properties Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) model here is built on Healthpeak Properties’ adjusted funds from operations and projects what those cash flows could be worth today. On this approach, the latest twelve month free cash flow is about $1.29b, with the model assuming a growing but relatively moderate cash flow profile over time rather than aggressive expansion.

When those projected cash flows are discounted back, the DCF indicates an estimated intrinsic value of about $38.09 per share. Compared with the current share price, this implies that Healthpeak Properties may be undervalued by around 43.1%, indicating that the market price is meaningfully below the value suggested by the company’s cash flow profile under these assumptions.

On this DCF view, Healthpeak Properties appears undervalued, with the intrinsic value estimate coming in well above the current share price.

Our Discounted Cash Flow (DCF) analysis suggests Healthpeak Properties is undervalued by 43.1%. Track this in your watchlist or portfolio, or discover 44 more high quality undervalued stocks.

Has Healthpeak Properties Run Too Far on Earnings?

P/E is usually a reasonable way to look at Healthpeak Properties because earnings are a key anchor for many real estate investors alongside cash flow. On this measure, the stock trades on a P/E of about 67.4x, which is well above the Health Care REITs industry average of 19.7x and also above the peer group average of 45.1x.

The tailored fair P/E ratio from the model is 21.1x. Because this benchmark is heavily penalising the company on factors like risk profile and earnings quality, it should be read less as a precise target and more as a sign that Healthpeak Properties screens as very expensive on earnings compared with what the model would usually ascribe to similar businesses.

On the P/E multiple, Healthpeak Properties stock currently appears expensive relative to both its sector peers and the model’s fair ratio benchmark.

The Healthpeak Properties Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Healthpeak Properties are designed to make clear which specific assumptions about Healthpeak Properties' future growth, margins and earnings would need to hold for the stock to be worth materially more or less than today's price. These narratives sit on the company's Community page. Instead of stopping at a single ratio or model output, they unpack the future path that figure relies on so you can monitor whether that story is playing out over time.

Community views on Healthpeak Properties sit far apart, with one side leaning into technology and demographics while the other is more focused on concentration and funding risks.

Bull case: 20% undervalued

"The company's early adoption of AI-driven operational platforms and data integration provides a scalable foundation for further labor productivity, cost reductions, and improved portfolio optimization..."

Bear case: roughly fairly valued

"Concentrated exposure to capital, regulatory, and tenant risks threatens Healthpeak's revenue stability, margin growth, and flexibility for investment or dividend expansion..."

Do you think there's more to the story for Healthpeak Properties? Head over to our Community to see what others are saying!

The Bottom Line

For Healthpeak Properties, the Discounted Cash Flow (DCF) intrinsic value estimate suggests meaningful upside relative to the current share price, while the market multiple view flags the stock as overvalued compared with peers and its tailored fair P/E. That split is reinforced by the low overall value score, which indicates the broader valuation checks are not especially supportive despite the DCF signal. The tension largely comes down to whether Healthpeak’s cash flows ultimately justify paying such a rich earnings multiple, especially given its funding needs and capital intensity. The key question from here is whether future cash flow delivery, and not just sentiment, can sustain today’s valuation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.